Adjuvant therapy can feasibly yield circulating tumor DNA (ctDNA) clearance in a portion of patients with colorectal cancer (CRC) and postoperative ctDNA positivity, with clearance correlating with superior disease-free survival (DFS) outcomes,…
Adjuvant Therapy Confers Postoperative ctDNA Clearance, DFS Benefit in CRC
